Depression and anxiety are common among patients with cardiovascular disease (CVD) and confer significant cardiac risk, contributing to CVD morbidity and mortality. Unfortunately, due to the lack of screening tools that address the specific needs of hospitalized patients, few cardiac inpatient programs offer routine screening for these forms of psychological distress, despite recommendations to do so.
Aims:
The purpose of this study was to validate single-item measures for depression and anxiety among cardiac inpatients.
Methods:
Consecutive inpatients were recruited from the cardiology and cardiac surgery step-down units at a university-affiliated, quaternary-care hospital. Subjects completed a questionnaire that included: (a) demographics, (b) single-item-measures for depression and anxiety (from the Screening Tool for Psychological Distress (STOP-D)), and (c) Hospital Anxiety and Depression Scale (HADS).
Results:
One hundred and five participants were recruited with a wide variety of cardiac diagnoses, having a mean age of 66 years, and 28% were women. Both STOP-D items were highly correlated with their corresponding validated measures and demonstrated robust receiver-operator characteristic curves. Severity scores on both items correlated well with established severity cut-off scores on the corresponding subscales of the HADS.
Conclusions:
The STOP-D is a self-administered, self-report measure using two independent items that provide severity scores for depression and anxiety. The tool performs very well compared with other previously validated measures. Requiring no additional scoring and being free, STOP-D offers a simple and valid method for identifying hospitalized cardiac patients who are experiencing psychological distress. This crucial first step triggers initiation of appropriate monitoring and intervention, thus reducing the likelihood of the adverse cardiac outcomes associated with psychological distress.
RozanskiABlumenthalJAKaplanJ. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation1999; 99: 2192–2217.
2.
HareDLToukhsatiSRJohanssonP. Depression and cardiovascular disease: A review. Eur Heart J2011; 19: 130–142.
3.
LichtmanJHBiggerJTJBlumenthalJA. Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation2008; 118: 1768–1775.
4.
LichtmanJHFroelicherESBlumenthalJA., on behalf of the American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the American Heart Association. Circulation2014; 129: 1350–1369.
5.
YusufSHawkenSOunpuuS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): A case control study. Lancet2004; 364: 937–952.
6.
WhooleyMAWongJM. Depression and cardiovascular disorders. Annu Rev Clin Psychol2013; 9: 327–354.
7.
BarthJSchumacherMHermann-LingenC. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med2004; 66: 802–813.
8.
WatkinsILKochGGSherwoodA. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc2013; 2: e000068.
9.
Frasure-SmithNLesperanceF. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry2008; 65: 62–71.
10.
RozanskiABlumenthalJADavidsonKW. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J Am Coll Cardiol2004; 45: 637–651.
11.
ZigmondASSnaithRP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand1983; 67: 361–370.
12.
BeckATSteerRABrownGK. Depression Inventory manual. Second ed.Antonio, Texas: The Psychological Corporation, 1996.
13.
BeckATSteerRA. Manual for the Beck Anxiety Inventory. San Antonio, Texas: The Psychological Corporation, 1990.
14.
KroenkeKSpitzerRLWilliamsJBW. The PHQ-9. J Gen Intern Med2001; 16: 606–613.
15.
PriorPFrancisJReitavJ. Behavioural, psychological, and functional issues. In: StoneJ (ed) Canadian guidelines for cardiac rehabilitation and CVD prevention. 3rd ed.Winnipeg, Manitoba: Canadian Association of Cardiac Rehabilitation, 2004, pp. 107–202.
16.
British Association for Cardiovascular Prevention and Rehabilitation (BACPR). The BACPR standards and core components for cardiovascular prevention and rehabilitation. 2nd ed.London: British Association for Cardiovascular Prevention and Rehabilitation, 2012.
17.
PerkJDe BackerGGohlkeH. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J2012; 33: 1635–1701.
18.
YoungQ-RIgnaszewskiAFofonoffD. Brief screen to identify 5 of the most common forms of psychosocial distress in cardiac patients: Validation of the screening tool for psychological distress. J Cardiovasc Nurs2007; 22: 525–534.
19.
RumsfeldJSJonesPGWhooleyMA. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J2005; 150: 961–967.
20.
RoestAMMartensEJde JongeP. Anxiety and risk of incident coronary heart disease: A meta-analysis. J Am Coll Cardiol2010; 56: 38–46.
21.
ChamberlainAMVickersKSColliganRC. Associations of preexisting depression and anxiety with hospitalization in patients with cardiovascular disease. Mayo Clin Proc2011; 86: 1056–1062.
22.
WangGCuiJWangY. Anxiety and adverse coronary artery disease outcomes in Chinese patients. Psychosom Med2013; 75: 530–536.
23.
ParkJHTahkSBaeSH. Depression and anxiety as predictors of recurrent cardiac events 12 months after percutaneous coronary interventions. J Cardiovasc Nurs2015; 30: 351–359.
24.
BarefootJSM. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation1996; 93: 1976–1980.
25.
LesperanceFFrasure-SmithNTalajicM. Five-year risk of cardiac mortality in relations to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation2002; 105: 1049–1053.
26.
KawachiIColditzGAAsherioA. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation1994; 89: 2225–2229.
27.
KawachiISparrowDVokonasPS. Symptoms of anxiety and risk of coronary heart disease: The normative aging study. Circulation1994; 90: 2225–2229.
28.
GraceSLAbbeySEIrvineJ. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother and Psychosom2004; 73: 344–352.
29.
MoserDKDracupK. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?Psychosom Med1996; 58: 395–401.
30.
TullyPJBennettsJSBakerRA. Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery. Heart Lung2011; 40: 4–11.
31.
ShenBJEisenbergSAMaedaU. Depression and anxiety predict decline in physical health functioning in patients with heart failure. Ann Behav Med2011; 41: 373–382.
32.
Tsuchihashi-MakayaMKatoNChishakiA. Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure. Circ J2009; 73: 280–287.
33.
ZiegelsteinRCKimSYKaoD. Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening?Psychosom Med2005; 67: 393–397.
34.
HuffmanJCSmithFABlaisMA. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol2006; 98: 319–324.
35.
DoyleFMcGeeHConroyR. Depression in cardiac patients: An evidence base for selection of brief screening instruments by nursing staff. Eur J Cardiovasc Nurs2007; 6: 89–91.
36.
HerrmannC. International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results. J Psychosom Res1997; 42: 17–41.
37.
BjellandIDahlAAHaugTT. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res2002; 52: 69–77.
38.
RobertsSBBonniciDMMackinnonAJ. Psychometric evaluation of the Hospital Anxiety and Depression Scale (HADS) among female cardiac patients. Br J Health Psychol2001; 6: 373–383.
39.
BambauerKZLockeSEAupontO. Using the Hospital Anxiety and Depression Scale to screen for depression in cardiac patients. Gen Hosp Psychiatry2005; 27: 275–284.
40.
FosterSLConeJD. Validity issues in clinical assessment. Psychol Assess1995; 7: 248–260.
41.
JohnOPSotoCJ. The importance of being valid: Reliability and the process of construct validation. In: RobinsRWFraleyRCKruegerRF (eds) Handbook of research methods in personality psychology. New York, NY: The Guilford Press, 2007, pp.461–494.
42.
CohenJ. A power primer. Psychol Bull1992; 112: 155–159.
43.
FawcettT. An introduction to ROC analysis. Pattern Recognit Lett2006; 27: 861–874.
44.
SwetsJPickettR. Evaluation of diagnostic systems: Methods from signal detection theory. New York: Academic Press, 1982.
45.
SwetsJA. Measuring the accuracy of diagnostic systems. Science1988; 240: 1285–1293.
46.
FischerJEBachmannLMJaeschkeR. A readers’ guide to the interpretation of diagnostic test properties: Clinical example of sepsis. Intensive Care Med2003; 29: 1043–1051.
